PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update
PharmaTher (PHRM) announced Q3 financial results including C$10.1M in cash. The company is focused on treating rare disorders with ketamine and creating novel methods of administering psychedelics.